Copyright © 2000 by the European Society of Cardiology.
European survey of primary care physician perceptions on heart failure diagnosis and management (Euro-HF)
Department of Primary Care and General Practice, Medical School, University of Birmingham, U.K.
revised March 6, 2000; accepted March 8, 2000
Abstract
Aims To survey a random sample of primary care physicians across six European countries regarding their perceptions of diagnostic and prescribing issues in heart failure, and to consider factors that might be associated with physician under-performance.
Methods and Results Qualitative, postal questionnaire-based, validated survey in the native tongue of a random sample of 200 primary care physicians in each of five European countries (France, Germany, Italy, The Netherlands and Spain) and of 250 U.K. primary care physicians. Respondents provided: details of practice characteristics; the usual way a diagnosis of heart failure was established; access to investigations; names of drugs prescribed in heart failure, with estimates of the proportion of patients supplied with particular classes; and physician attitudes regarding the evidence base (in terms of benefits and risks) for treatments used. Outcomes were physician perceptions and attitudes about heart failure diagnosis and treatment. Adjusted response rates varied from 17% (France) to 56% (Britain). Primary care physicians underestimate the prevalence of heart failure. Most patients are diagnosed on symptoms and signs alone, with only 32% having further investigations or referral. Although most primary care physicians stated they prescribe ACE inhibitors in heart failure, this was for only 47–62% of patients, and at doses below those identified as effective in trials. Most prescribing doctors (91%) believe there is strong evidence of reduced mortality in heart failure patients using ACE inhibitors, but 51% also consider ACE inhibitors have substantial risks with their use.
Conclusion Limitations of the data include the general problem of questionnaires, whether responses accord with actual clinical practice, and, specific to these data, the low response rate in some countries (although the study does provide information from nearly 300 randomly selected primary care physicians across Europe). New preliminary insights include exposition of the ‘low tech’ approach to heart failure diagnosis across Europe: doctors report the use of symptoms and signs alone; the lack of direct (open) access to objective investigations, such as echocardiography, which almost guarantees that misdiagnoses will occur; and the under-utilization and under-dosing with ACE inhibitors. The main factor influencing under-use would appear to be the exaggerated perceptions of treatment risk amongst primary care physicians that dominate the widespread and accurate knowledge of treatment benefits.
Key Words: Primary care, perceptions, heart failure, diagnosis, management
f1 Correspondence: Richard Hobbs, Professor of Primary Care and General Practice, Department of Primary Care and General Practice, Medical School, University of Birmingham, U.K.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  F.D.R. Hobbs Clinical burden and health service challenges of chronic heart failure Eur J Heart Fail Suppl, April 1, 2009; 8(suppl_1): i1 - i4. [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Kelley, S. S. Mehta, and M. Carrington Reid Management of Patients with ICDs at the End of Life (EOL): A Qualitative Study American Journal of Hospice and Palliative Medicine, January 1, 2009; 25(6): 440 - 446. [Abstract] [PDF]
|
|
|
|
 |
|
 W. J. Remme, J. J.V. McMurray, F.D. R. Hobbs, A. Cohen-Solal, J. Lopez-Sendon, A. Boccanelli, F. Zannad, B. Rauch, K. Keukelaar, C. Macarie, et al. Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians Eur. Heart J., July 2, 2008; 29(14): 1739 - 1752. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. D. Schocken, E. J. Benjamin, G. C. Fonarow, H. M. Krumholz, D. Levy, G. A. Mensah, J. Narula, E. S. Shor, J. B. Young, and Y. Hong Prevention of Heart Failure: A Scientific Statement From the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group Circulation, May 13, 2008; 117(19): 2544 - 2565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. B. Sturm, F. M. Haaijer-Ruskamp, N. J. Veeger, C. P. Balje-Volkers, K. Swedberg, and W. H. van Gilst The relevance of comorbidities for heart failure treatment in primary care: A European survey Eur J Heart Fail, January 1, 2006; 8(1): 31 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. Remme, J. J.V. McMurray, B. Rauch, F. Zannad, K. Keukelaar, A. Cohen-Solal, J. Lopez-Sendon, F.D. R. Hobbs, D. E. Grobbee, A. Boccanelli, et al. Public awareness of heart failure in Europe: first results from SHAPE Eur. Heart J., November 2, 2005; 26(22): 2413 - 2421. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. McMurray, A. Cohen-Solal, R. Dietz, E. Eichhorn, L. Erhardt, F.D. R. Hobbs, H. Krum, A. Maggioni, R. S. McKelvie, I. L. Pina, et al. Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: Putting guidelines into practice Eur J Heart Fail, August 1, 2005; 7(5): 710 - 721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.D. R. Hobbs, J. Korewicki, J. G.F. Cleland, J. Eastaugh, N. Freemantle, and on behalf of the IMPROVEMENT Investigators The diagnosis of heart failure in European primary care: The IMPROVEMENT Programme survey of perception and practice Eur J Heart Fail, August 1, 2005; 7(5): 768 - 779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schuchert and On behalf of the BISEX Investigators (Appendix A) Effects of bisoprolol treatment for chronic heart failure initiated and followed up by primary care physicians Eur J Heart Fail, June 1, 2005; 7(4): 604 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Martensson, A. Stromberg, U. Dahlstrom, J.-E. Karlsson, and B. Fridlund Patients with heart failure in primary health care: effects of a nurse-led intervention on health-related quality of life and depression Eur J Heart Fail, March 16, 2005; 7(3): 393 - 403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ceia, C. Fonseca, T. Mota, H. Morais, F. Matias, C. Costa, and A. G. Oliveira Aetiology, comorbidity and drug therapy of chronic heart failure in the real world: the EPICA substudy Eur J Heart Fail, October 1, 2004; 6(6): 801 - 806. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F D R Hobbs, R C Davis, A K Roalfe, R Hare, and M K Davies Reliability of N-terminal proBNP assay in diagnosis of left ventricular systolic dysfunction within representative and high risk populations Heart, August 1, 2004; 90(8): 866 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Komajda, B. Lutiger, H. Madeira, K. Thygesen, M. Bobbio, P. Hildebrandt, W. Jaarsma, G. Riegger, L. Ryden, A. Scherhag, et al. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN) Eur J Heart Fail, June 1, 2004; 6(4): 467 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bayes-Genis, M. Santalo-Bel, E. Zapico-Muniz, L. Lopez, C. Cotes, J. Bellido, R. Leta, P. Casan, and J. Ordonez-Llanos N-terminal probrain natriuretic peptide (NT-proBNP) in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricular dysfunction Eur J Heart Fail, March 15, 2004; 6(3): 301 - 308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. C. Vourvouri, A. F.L. Schinkel, J. R.T.C. Roelandt, F. Boomsma, G. Sianos, M. Bountioukos, F. B. Sozzi, V. Rizzello, J. J. Bax, H. I. Karvounis, et al. Screening for left ventricular dysfunction using a hand-carried cardiac ultrasound device Eur J Heart Fail, December 1, 2003; 5(6): 767 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Wright, R. N. Doughty, A. Pearl, G. D. Gamble, G. A. Whalley, H. J. Walsh, G. Gordon, W. Bagg, H. Oxenham, T. Yandle, et al. Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: A randomized, controlled trial J. Am. Coll. Cardiol., November 19, 2003; 42(10): 1793 - 1800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Senior, G Galasko, J V McMurray, and J Mayet Screening for left ventricular dysfunction in the community: role of hand held echocardiography and brain natriuretic peptides Heart, November 1, 2003; 89(90003): iii24 - 28. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Murray-Thomas and M. R Cowie Epidemiology and clinical aspects of congestive heart failure Journal of Renin-Angiotensin-Aldosterone System, September 1, 2003; 4(3): 131 - 136. [Abstract] [PDF]
|
|
|
|
 |
|
 A. K. Kakkar, M. Levine, H.M. Pinedo, R. Wolff, and J. Wong Venous Thrombosis in Cancer Patients: Insights from the FRONTLINE Survey Oncologist, August 1, 2003; 8(4): 381 - 388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. H. Rutten, D. E. Grobbee, and A. W. Hoes Diagnosis and management of heart failure: a questionnaire among general practitioners and cardiologists Eur J Heart Fail, June 1, 2003; 5(3): 345 - 348. [Full Text] [PDF]
|
|
|
|
|
|
M. L. Bouvy, E. R. Heerdink, H. G.M. Leufkens, and A. W. Hoes Patterns of pharmacotherapy in patients hospitalised for congestive heart failure Eur J Heart Fail, March 1, 2003; 5(2): 195 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Fuat, A P. S Hungin, and J. J. Murphy Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study BMJ, January 25, 2003; 326(7382): 196 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.R. Cowie The fine art of prognostication Eur. Heart J., December 1, 2002; 23(23): 1804 - 1806. [Full Text] [PDF]
|
|
|
|
|
|
K. Khunti, H. Hearnshaw, R. Baker, and G. Grimshaw Heart failure in primary care: qualitative study of current management and perceived obstacles to evidence-based diagnosis and management by general practitioners Eur J Heart Fail, December 1, 2002; 4(6): 771 - 777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R C Davis, F D R Hobbs, J E Kenkre, A K Roalfe, R Hare, R J Lancashire, and M K Davies Prevalence of left ventricular systolic dysfunction and heart failure in high risk patients: community based epidemiological study BMJ, November 16, 2002; 325(7373): 1156 - 1156. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F D R Hobbs Unmet need for diagnosis of heart failure: the view from primary care Heart, October 1, 2002; 88(90002): ii9 - 11. [Full Text] [PDF]
|
|
|
|
|
|
I. Ekman and K. Swedberg Home-based management of patients with chronic heart failure--focus on content not just form! Eur. Heart J., September 1, 2002; 23(17): 1323 - 1325. [Full Text] [PDF]
|
|
|
|
|
|
F D R Hobbs, R C Davis, A K Roalfe, R Hare, M K Davies, and J E Kenkre Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations BMJ, June 22, 2002; 324(7352): 1498 - 1498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.J. Block, D. Schoors, and G. van Camp Substantial variations in clinical outcome following hospitalization for heart failure Eur. Heart J., April 2, 2002; 23(8): 597 - 599. [Full Text] [PDF]
|
|
|
|
|
|
J. McMurray, A. Cohen-Solal, R. Dietz, E. Eichhorn, L. Erhardt, R. Hobbs, A. Maggioni, I. Pina, J. Soler-Soler, and K. Swedberg Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practice Eur J Heart Fail, August 1, 2001; 3(4): 495 - 502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Tognoni Parallel realities of guidelines and practice Eur. Heart J., November 2, 2000; 21(22): 1819 - 1821. [PDF]
|
|